Transaction · 0001415889-25-004532

WILSON KAREN J

WILSON KAREN J, DIR, reported a transaction classified as grant at LAVA Therapeutics NV involving 33390.000000 shares for an estimated $0.00. Reported holdings after the transaction were 33390.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ADIR
LVTXLAVA Therapeutics NV
Filing timeFeb 19
Trade dateFeb 13, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
…
Pre-filing
…
Returns since
…

LVTX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
LVTX since 2025-02-19Filed 562 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001415889-25-004532
Common Shares (Right to Buy)
Transaction date
Feb 13, 2025
Filed Feb 19, 2025, 01:15 AM · 6d delay
Shares
33.3k sh
$0 per share
Estimated value
$0
Computed from shares × price
Holdings after
33.3k sh
Direct

Filing warnings

Notes recorded with this filing
1 warning
delayed filingThe filing was reported 6 calendar days after the transaction date.

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Delayed Filing Derivative Transaction Direct Ownership Large Holdings Increase
-16score
Filing-only score

-16

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    100% of the shares underlying the option will vest on February 13, 2026, provided the Reporting Person remains in a service relationship with the Issuer or a subsidiary of the Issuer on such vesting d…

Original filing · 0001415889-25-004532
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

LVTX